Otonomy, Inc.
OTICDelisted Dec 29, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001493566
Otonomy, Inc. was delisted on Dec 29, 2022; its insiders filed their last Form 4 on Dec 30, 2022; 40 institutions reported holding it in 13F filings for Q3 2022, worth $8.42M in total; no superinvestor held it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 40
- Q3 2022, −10 vs. previous quarter
- 13F value
- $8.42M
- Reported value at the end of Q3 2022
- Superinvestors holding
- 0
- At the end of Q3 2022
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2021
- $125.0K
- −54.2% year over year
- Net income, FY2021
- -$51.2M
- No comparable prior period
- Free cash flow, FY2021
- -$42.7M
- No comparable prior period
- Revenue, Q3 FY2022
- $0
- No comparable prior period
Superinvestors holding OTIC, Q3 2022
Go to the superinvestors tabNo superinvestor reported holding OTIC at the end of Q3 2022.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Otonomy, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 29, 2022 (view filing)4:18 PM ET | Nov 28 | 1 day | Capps Vickie LDirector | SSale | −42.2K | $0.1028 | −$4.34K | −92.6%3.40K after | |
| Mar 29, 2022 (view filing) | Mar 25-28 | 4 days | Weber David AllenPresident & CEO | SSale | −19.3K | $2.40 | −$46.3K | −4.9%377.5K after | 2 lots |
| Mar 29, 2022 (view filing) | Mar 25-28 | 4 days | Savel Robert Michael IIChief Technical Officer | SSale | −5.70K | $2.40 | −$13.7K | −3.8%145.7K after | 2 lots |
| Mar 29, 2022 (view filing) | Mar 25-28 | 4 days | Foster Alan CharlesChief Scientific Officer | SSale | −4.39K | $2.40 | −$10.5K | −2.4%177.0K after | 2 lots |
| Mar 29, 2022 (view filing) | Mar 25-28 | 4 days | Cayer Paul ECh. Financial & Business Offcr | SSale | −9.64K | $2.40 | −$23.1K | −4.1%223.8K after | 2 lots |
Top 10 13F holders, Q3 2022
See all 40 holdersThe largest institutional positions in Otonomy, Inc. at the end of Q3 2022; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 8,443,134 | $2.49M | 0.02% | +30,500+0.4% | Added |
| Point72 Asset Management, L.P. | 5,495,000 | $1.62M | 0.01% | +5,495,000 | New |
| Suvretta Capital Management, LLC | 3,144,196 | $928.0K | 0.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,430,454 | $717.0K | 0.00% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 2,312,880 | $682.0K | 0.62% | +2,282,880+7,609.6% | Added |
| DAFNA Capital Management LLC | 1,470,199 | $434.0K | 0.12% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 851,000 | $251.0K | 0.16% | −800.0% | Reduced |
| BlackRock Inc. | 786,672 | $232.0K | 0.00% | −4,149−0.5% | Reduced |
| Geode Capital Management, LLC | 466,500 | $137.0K | 0.00% | +966+0.2% | Added |
| Schonfeld Strategic Advisors LLC | 461,018 | $136.0K | 0.00% | +461,018 | New |